1,403
Views
0
CrossRef citations to date
0
Altmetric
Short Communication

Genome-Wide Association Study of Liver Enzyme Elevation in Rheumatoid Arthritis Patients Starting Methotrexate

ORCID Icon, , ORCID Icon, , , ORCID Icon, ORCID Icon, ORCID Icon & ORCID Icon show all
Pages 973-982 | Received 26 May 2021, Accepted 31 Aug 2021, Published online: 15 Sep 2021

References

  • Singh JA , SaagKG , BridgesSLJret al. 2015 American College of Rheumatology Guideline for the Treatment of Rheumatoid Arthritis. Arthritis Rheumatol.68(1), 1–26 (2016).
  • Visser K , VanDer Heijde DM. Risk and management of liver toxicity during methotrexate treatment in rheumatoid and psoriatic arthritis: a systematic review of the literature. Clin. Exp. Rheumatol.27(6), 1017–1025 (2009).
  • Karlsson Sundbaum J , ErikssonN , HallbergP , LehtoN , WadeliusM , BaecklundE. Methotrexate treatment in rheumatoid arthritis and elevated liver enzymes: a long-term follow-up of predictors, surveillance, and outcome in clinical practice. Int. J. Rheum. Dis.22(7), 1226–1232 (2019).
  • Song GG , BaeS-C , LeeYH. Association of the MTHFR C677T and A1298C polymorphisms with methotrexate toxicity in rheumatoid arthritis: a meta-analysis. Clin. Rheumatol.33(12), 1715–1724 (2014).
  • Karlsson Sundbaum J , BaecklundE , ErikssonN , HallbergP , KohnkeH , WadeliusM. MTHFR, TYMS and SLCO1B1 polymorphisms and adverse liver effects of methotrexate in rheumatoid arthritis. Pharmacogenomics21(5), 337–346 (2020).
  • Lima A , SeabraV , BernardesM , AzevedoR , SousaH , MedeirosR. Role of key TYMS polymorphisms on methotrexate therapeutic outcome in portuguese rheumatoid arthritis patients. PLoS ONE9(10), e108165–e108165 (2014).
  • Jekic B , LukovicL , BunjevackiVet al. Association of the TYMS 3G/3G genotype with poor response and GGH 354GG genotype with the bone marrow toxicity of the methotrexate in RA patients. Eur. J. Clin. Pharm.69(3), 377–383 (2013).
  • Lima A , BernardesM , AzevedoRet al. SLC19A1, SLC46A1 and SLCO1B1 polymorphisms as predictors of methotrexate-related toxicity in Portuguese rheumatoid arthritis patients. Toxicol. Sci.142(1), 196–209 (2014).
  • Grk M , MilicV , DolzanVet al. Analysis of association of ADORA2A and ADORA3 polymorphisms genotypes/haplotypes with efficacy and toxicity of methotrexate in patients with Rheumatoid arthritis. Pharmacogenomics J.20(6), 784–791 (2020).
  • Eslam M , ValentiL , RomeoS. Genetics and epigenetics of NAFLD and NASH: clinical impact. J. Hepatol.68(2), 268–279 (2018).
  • Kawaguchi T , ShimaT , MizunoMet al. Risk estimation model for nonalcoholic fatty liver disease in the Japanese using multiple genetic markers. PLoS ONE13(1), e0185490–e0185490 (2018).
  • Di Costanzo A , BelardinilliF , BailettiDet al. Evaluation of polygenic determinants of non-alcoholic fatty liver disease (NAFLD) By a candidate genes resequencing strategy. Sci. Rep.8(1), 3702–3702 (2018).
  • Namjou B , LingrenT , HuangYet al. GWAS and enrichment analyses of non-alcoholic fatty liver disease identify new trait-associated genes and pathways across eMERGE Network. BMC Medicine17(1), 135 (2019).
  • Chalasani N , GuoX , LoombaRet al. Genome-wide association study identifies variants associated with histologic features of nonalcoholic fatty liver disease. Gastroenterology139(5), 1567–1576 (2010).
  • Chambers JC , ZhangW , SehmiJet al. Genome-wide association study identifies loci influencing concentrations of liver enzymes in plasma. Nat. Genet.43(11), 1131–1138 (2011).
  • Kanai M , AkiyamaM , TakahashiAet al. Genetic analysis of quantitative traits in the Japanese population links cell types to complex human diseases. Nat. Genet.50(3), 390–400 (2018).
  • Speliotes EK , Yerges-ArmstrongLM , WuJet al. Genome-wide association analysis identifies variants associated with nonalcoholic fatty liver disease that have distinct effects on metabolic traits. PLoS Genetics7(3), e1001324 (2011).
  • Arnett FC , EdworthySM , BlochDAet al. The American rheumatism association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum.31(3), 315–324 (1988).
  • Aletaha D , NeogiT , SilmanAJet al. 2010 Rheumatoid arthritis classification criteria: An American College of Rheumatology/European League Against Rheumatism collaborative initiative. Arthritis Rheum.62(9), 2569–2581 (2010).
  • Schmajuk G , MiaoY , YazdanyJ , BoscardinWJ , DaikhDI , SteinmanMA. Identification of risk factors for elevated transaminases in methotrexate users through an electronic health record. Arthritis Care Res. (Hoboken)66(8), 1159–1166 (2014).
  • Chang CC , ChowCC , TellierLC , VattikutiS , PurcellSM , LeeJJ. Second-generation PLINK: rising to the challenge of larger and richer datasets. Gigascience4, 7 (2015).
  • Sham PC , PurcellSM. Statistical power and significance testing in large-scale genetic studies. Nat. Rev. Genet.15(5), 335–346 (2014).
  • Kundaje A , MeulemanW , ErnstJet al. Integrative analysis of 111 reference human epigenomes. Nature518(7539), 317–330 (2015).
  • Consortium EP . An integrated encyclopedia of DNA elements in the human genome. Nature489(7414), 57–74 (2012).
  • Lonsdale J , ThomasJ , SalvatoreMet al. The Genotype-Tissue Expression (GTEx) project. Nat. Genet.45(6), 580–585 (2013).
  • Sahlén P , AbdullayevI , RamsköldDet al. Genome-wide mapping of promoter-anchored interactions with close to single-enhancer resolution. Genome Biol.16(1), 156 (2015).
  • Cavalli M , DiamantiK , PanGet al. A multi-omics approach to liver diseases: integration of single nuclei transcriptomics with proteomics and HiCap bulk data in human liver. OMICS24(4), 180–194 (2020).
  • Henneberg B , SwiniarskiS , SabineB , IllenbergerS. A conserved peptide motif in Raver2 mediates its interaction with the polypyrimidine tract-binding protein. Exp. Cell Res.316(6), 966–979 (2010).
  • Bartoletti-Stella A , GaspariniL , GiacominiCet al. Messenger RNA processing is altered in autosomal dominant leukodystrophy. Hum. Mol. Genet.26(19), 3868–3868 (2017).
  • Uhlén M , FagerbergL , HallströmBMet al. Tissue-based map of the human proteome. Science347(6220), 1260419 (2015).
  • Liu W , WangK , LvXet al. Up-regulation of RNA binding proteins contributes to folate deficiency-induced neural crest cells dysfunction. Int. J. Biol. Sci.16(1), 85–98 (2020).
  • Bouzid D , FouratiH , AmouriAet al. Association of the RAVER2 gene with increased susceptibility for ulcerative colitis. Hum. Immunol.73(7), 732–735 (2012).
  • Choy EHS , Miceli-RichardC , González-GayMAet al. The effect of JAK1/JAK2 inhibition in rheumatoid arthritis: efficacy and safety of baricitinib. Clin. Exp. Rheumatol.37(4), 694–704 (2019).
  • Gremese E , AliverniniS , TolussoB , ZeidlerMP , FerraccioliG. JAK inhibition by methotrexate (and csDMARDs) may explain clinical efficacy as monotherapy and combination therapy. J. Leukoc. Biol.106(5), 1063–1068 (2019).
  • Mueller RB , HaslerC , PoppFet al. Effectiveness, tolerability, and safety of tofacitinib in rheumatoid arthritis: a retrospective analysis of real-world data from the St. Gallen and Aarau Cohorts. J. Clin. Med.8(10), 1548 (2019).
  • Wu Z-P , ZhangP , BaiJ-Z , LiangY , HeJ-S , WangJ-C. Efficacy and safety of baricitinib for active rheumatoid arthritis in patients with an inadequate response to conventional synthetic or biological disease-modifying anti-rheumatic drugs: a meta-analysis of randomized controlled trials. Exp. Ther. Med.16(3), 2449–2459 (2018).
  • Serhal L , EdwardsCJ. Upadacitinib for the treatment of rheumatoid arthritis. Expert Rev. Clin. Immunol.15(1), 13–25 (2019).
  • Da Cunha VR , BrenolCV , BrenolJCTet al. Metabolic syndrome prevalence is increased in rheumatoid arthritis patients and is associated with disease activity. Scand. J. Rheumatol.41(3), 186–191 (2012).
  • Langman G , HallPDLM , ToddG. Role of non-alcoholic steatohepatitis in methotrexate-induced liver injury. J. Gastroenterol. Hepatol.16(12), 1395–1401 (2001).
  • Maranville JC , CoxNJ. Pharmacogenomic variants have larger effect sizes than genetic variants associated with other dichotomous complex traits. Pharmacogenomics J.16(4), 388–392 (2016).